Related Experiment Video

Updated: Aug 13, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

[Clinicopathological implications of gene alterations in breast cancer]

H Tsuda1

  • 1Pathology Division, National Cancer Center Research Institute, Tokyo.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|October 1, 1993
PubMed

Insights

DNA alterations like c-erbB-2 amplification and p53 mutation in breast cancer correlate with tumor grade. These genetic changes may predict patient prognosis and guide therapy decisions, even independent of tumor size or lymph node status.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Human breast cancer exhibits numerous DNA alterations with significant clinical and pathological implications.
  • Specific gene alterations, including c-erbB-2 proto-oncogene amplification and p53 tumor-suppressor gene mutation, are frequently observed.

Purpose of the Study:

  • To examine the clinical and pathological implications of DNA alterations in human breast cancer.
  • To assess the prognostic value of c-erbB-2 and p53 alterations in breast cancer patients.

Main Methods:

  • Analysis of DNA alterations in human breast cancer samples.
  • Correlation of gene alterations (c-erbB-2 amplification, p53 mutation) with protein levels, histologic grade, tumor size, and lymph node status.

Main Results:

  • Amplification of c-erbB-2 and mutation of p53 showed a strong correlation with the histologic grade of atypia.
  • These genetic alterations appear to be prognostic factors, potentially independent of tumor size or lymph node status.

Conclusions:

  • c-erbB-2 and p53 alterations are associated with breast cancer grade and may serve as independent prognostic indicators.
  • Further research is needed to confirm their prognostic significance, especially in node-negative patients, to aid in predicting prognosis and determining adjuvant systemic therapy.

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...